Skip to main content

Novo clinches AI-driven drug deal worth as much as $2.7B

By Bloomberg  
   September 26, 2023

Novo Nordisk A/S agreed to partner with the U.S. technology company Valo Health Inc. to use AI to find new drugs in a deal that could be worth as much as $2.7 billion.

Full story

Get the latest on healthcare leadership in your inbox.